|
Geoffrey Henson, PhD joined Inhibitex as Senior Vice President of Drug Development in 2007. Previously he served as CEO, President and Secretary of FermaVir Pharmaceuticals, Inc. from 2005 to 2007. From 2003 to March 2005, Dr. Henson was a pharmaceutical consultant. He was a founder and Chief Operating Officer of AnorMED, a Canadian biopharmaceutical company from 1996-2003. Prior to that, he held a number of management and scientific positions in the Biomedical Research Group at Johnson Matthey from 1985-1996. From 1982-1985, Dr Henson was a researcher and member of the Basel Institute for Immunology in Basel, Switzerland. From 1978-1981, Dr. Henson did post-doctoral research at the Roswell Park Memorial Cancer Institute. Dr. Henson obtained his M.S. and Ph.D. in Biochemistry from New Mexico State University, and B.S. in Chemistry from Dickinson College. | 